Differential expression of versican isoforms is a component of the human melanoma cell differentiation process

Clelia Domenzain, María José Docampo, Montserrat Serra, Laia Miquel, Anna Bassols

Research output: Contribution to journalArticleResearchpeer-review

18 Citations (Scopus)

Abstract

Versican is a large chondroitin sulfate proteoglycan produced by human melanoma cell lines and malignant melanocytic lesions. In the present work, we have analyzed the expression of versican spliced variants V0, V1, V2 and V3 in human melanoma cell lines at several differentiation degrees. The isoform expression pattern depends on the degree of cell differentiation. Differentiated cell lines do not produce any of the versican isoforms as analyzed by Western blot, Northern blot and RT-PCR. All cell lines with an early or intermediate degree of differentiation (AX3, SK-mel-37, Rider, SK-mel-1.36-1-5 and SK-mel-3.44) expressed V0 and V1 transcripts, whereas V2 and V3 expression was shown only by the undifferentiated cell lines SK-mel-1.36-1-5 and Rider. Furthermore, we have analyzed the expression of versican isoforms in SK-mel-3.44 and SK-mel-1.36-1-5 cells induced to differentiate by TPA treatment. The expression of the large V0, V1 and V2 isoforms practically disappears in differentiated cells, whereas V3 remains detectable by RT-PCR analysis. © 2003 Elsevier B.V. All rights reserved.
Original languageEnglish
Pages (from-to)107-114
JournalBiochimica et Biophysica Acta - Molecular Cell Research
Volume1642
Issue number1-2
DOIs
Publication statusPublished - 23 Sep 2003

Keywords

  • Cell differentiation
  • Melanoma
  • Proteoglycan
  • Versican

Fingerprint Dive into the research topics of 'Differential expression of versican isoforms is a component of the human melanoma cell differentiation process'. Together they form a unique fingerprint.

Cite this